Company Filing History:
3 out of 376 
3 out of 2,100 
1 out of 462 
Years Active: 1997-2000
Title: The Innovations of James C. Vary, Jr.
Introduction
James C. Vary, Jr. is a notable inventor based in Seattle, Washington. He has made significant contributions to the field of microbiology, particularly in relation to Escherichia coli O157:H7. With a total of three patents to his name, Vary's work has implications for both medical research and public health.
Latest Patents
One of his latest patents focuses on the epithelial adhesion of Escherichia coli O157:H7. This patent includes polypeptides encoded by a continuous segment of chromosomal DNA from E. coli O157:H7, which are isolated on plasmid pSC(overlap) (ATCC No. 69648). These polypeptides encode an adhesin that mediates bacterial colonization of bovine intestines. Additionally, the patent discusses vaccines derived from this research and antibodies directed against the adhesin.
Career Highlights
Throughout his career, Vary has worked with prestigious institutions such as Children's Hospital Medical Center and the University of Washington. His research has contributed to a better understanding of bacterial infections and potential vaccine development.
Collaborations
James C. Vary, Jr. has collaborated with esteemed colleagues, including Phillip I. Tarr and Sima S. Bilge. Their combined expertise has furthered research in the field of microbiology and vaccine development.
Conclusion
James C. Vary, Jr. is a prominent inventor whose work on Escherichia coli O157:H7 has the potential to impact public health significantly. His contributions to microbiology and vaccine research are noteworthy and continue to influence the field.